JP2024522817A5 - - Google Patents
Info
- Publication number
- JP2024522817A5 JP2024522817A5 JP2023578136A JP2023578136A JP2024522817A5 JP 2024522817 A5 JP2024522817 A5 JP 2024522817A5 JP 2023578136 A JP2023578136 A JP 2023578136A JP 2023578136 A JP2023578136 A JP 2023578136A JP 2024522817 A5 JP2024522817 A5 JP 2024522817A5
- Authority
- JP
- Japan
- Prior art keywords
- arylideneamino
- nitrophenyl
- pyrrole
- pharmaceutically acceptable
- solid oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21180708 | 2021-06-21 | ||
| EP21180708.6 | 2021-06-21 | ||
| EP21180702.9 | 2021-06-21 | ||
| EP21180702 | 2021-06-21 | ||
| EP21209855 | 2021-11-23 | ||
| EP21209855.2 | 2021-11-23 | ||
| PCT/EP2022/066906 WO2022268825A1 (en) | 2021-06-21 | 2022-06-21 | Phenyl pyrrole aminoguanidine salts and formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522817A JP2024522817A (ja) | 2024-06-21 |
| JP2024522817A5 true JP2024522817A5 (https=) | 2025-06-30 |
Family
ID=84544160
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578832A Pending JP2024523459A (ja) | 2021-06-21 | 2022-06-21 | フェニルピロールアミノグアニジンの塩及びフェニルピロールアミノグアニジウム塩の多形体 |
| JP2023578136A Pending JP2024522817A (ja) | 2021-06-21 | 2022-06-21 | フェニルピロールアミノグアニジン塩及び製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578832A Pending JP2024523459A (ja) | 2021-06-21 | 2022-06-21 | フェニルピロールアミノグアニジンの塩及びフェニルピロールアミノグアニジウム塩の多形体 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20230271922A9 (https=) |
| EP (3) | EP4359076B1 (https=) |
| JP (2) | JP2024523459A (https=) |
| KR (2) | KR20240024818A (https=) |
| AU (2) | AU2022296767A1 (https=) |
| BR (1) | BR112023026909A2 (https=) |
| CA (2) | CA3220753A1 (https=) |
| ES (1) | ES3045575T3 (https=) |
| IL (2) | IL309102A (https=) |
| MX (2) | MX2023014174A (https=) |
| WO (2) | WO2022268814A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120617247A (zh) * | 2020-03-31 | 2025-09-12 | 西奈克制药有限公司 | 症状性病毒性疾病的治疗 |
| EP4359076B1 (en) * | 2021-06-21 | 2025-08-06 | SynAct Pharma ApS | Phenyl pyrrole aminoguanidine salts and formulations |
| WO2023218048A1 (en) * | 2022-05-12 | 2023-11-16 | Synact Pharma Aps | Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and atherosclerosis |
| CN120584099A (zh) * | 2022-12-21 | 2025-09-02 | 西奈克制药有限公司 | 苯基吡咯肼甲脒化合物的多晶型物 |
| WO2025124760A1 (en) | 2023-12-11 | 2025-06-19 | Synact Pharma Aps | Treatment of subpopulation of patients with rheumatoid arthritis |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9604348D0 (sv) | 1996-11-26 | 1996-11-26 | Wapharm Ab | Användning av hydroxyguanidiner |
| WO1999021571A1 (en) | 1997-10-27 | 1999-05-06 | Trega Biosciences, Inc. | Melanocortin receptor ligands and methods of using same |
| EP1076649A4 (en) | 1998-04-28 | 2010-06-02 | Trega Biosciences Inc | ISOQUINOLINE-BASED COMPOUNDS IN PLACE OF MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USE |
| WO1999064002A1 (en) | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
| CA2368431C (en) | 1999-03-29 | 2006-01-24 | The Procter & Gamble Company | Melanocortin receptor ligands |
| CA2377369A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
| WO2001005401A1 (en) | 1999-07-16 | 2001-01-25 | Trega Biosciences, Inc. | Melanocortin receptor-3 ligands to treat sexual dysfunction |
| US6720317B1 (en) | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| CZ2002959A3 (cs) | 1999-09-17 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | Inhibitory faktoru Xa |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| ES2316383T3 (es) | 1999-09-17 | 2009-04-16 | Millennium Pharmaceuticals, Inc. | Benzamidas e inhibidores relacionados del factor xa. |
| GB0002059D0 (en) | 2000-01-28 | 2000-03-22 | Melacure Therapeutics Ab | Novel aromatic amines |
| WO2001055106A2 (en) | 2000-01-28 | 2001-08-02 | Melacure Therapeutics Ab | Novel melanocortin receptor agonists and antagonists |
| WO2001055107A2 (en) | 2000-01-28 | 2001-08-02 | Melacure Therapeutics Ab | Aromatic amines and amides acting on the melanocortin receptors |
| KR100440370B1 (ko) | 2000-04-01 | 2004-07-19 | (주)명문엘씨 | 2중 사출에 의한 밀폐용기 뚜껑 |
| GB0019357D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
| US6768024B1 (en) | 2000-08-04 | 2004-07-27 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
| GB0019359D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel guanidines |
| DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
| EP1370211A4 (en) | 2001-03-02 | 2005-02-09 | Bristol Myers Squibb Co | SIMULTANEOUS ADMINISTRATION OF MELANOCORTIN RECEPTOR AGONISTS AND A PHOSPHODIESTERASE HEMMER FOR THE TREATMENT OF DISEASES RELATED TO CYCLIC AMP |
| GB0119172D0 (en) | 2001-08-06 | 2001-09-26 | Melacure Therapeutics Ab | Phenyl pyrrole derivatives |
| CA2363528A1 (en) | 2001-11-19 | 2003-05-19 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Immediate release tablet containing naproxen sodium |
| GB2398299A (en) | 2003-02-13 | 2004-08-18 | Melacure Therapeutics Ab | Pharmaceutically active phenyl-pyrrole derivatives |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| NZ573457A (en) * | 2006-06-09 | 2011-06-30 | Action Pharma As | Phenyl pyrrole aminoguanidine derivatives |
| GB0624987D0 (en) | 2006-12-14 | 2007-01-24 | Acure Pharma Ab | Novel aminoguanidines as melanocortin receptor ligands |
| EP2045250A1 (en) | 2007-09-26 | 2009-04-08 | Action Pharma A/S | Ring-substituted phenyl pyrrole aminoguanidine derivatives |
| WO2009071101A1 (en) | 2007-12-07 | 2009-06-11 | Action Pharma A/S | N-modified aminoguanidine derivatives |
| WO2009074157A1 (en) | 2007-12-13 | 2009-06-18 | Action Pharma A/S | Fully-modified phenyl pyrrole aminoguanidines |
| JP2011190199A (ja) | 2010-03-12 | 2011-09-29 | Hideto Nakamura | 関節リウマチ薬 |
| RU2668791C2 (ru) | 2012-10-19 | 2018-10-02 | ТиЭксПи ФАРМА ГМБХ | АНАЛОГИ АЛЬФА- и ГАММА-MSH |
| WO2015162486A1 (en) | 2014-04-22 | 2015-10-29 | Txp Pharma Gmbh | Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues |
| WO2015162483A1 (en) | 2014-04-22 | 2015-10-29 | Txp Pharma Gmbh | Alpha- and gamma-msh analogues |
| WO2017141343A1 (ja) | 2016-02-16 | 2017-08-24 | 三菱電機株式会社 | 圧縮機 |
| CN112292125B (zh) * | 2018-06-22 | 2023-10-31 | 西奈克制药有限公司 | 蛋白尿的治疗 |
| WO2020107221A1 (en) | 2018-11-27 | 2020-06-04 | Tsinghua University | Chemical activators of nicotinamide mononucleotide adenlyly transferase 2 (nmnat2) and uses thereof |
| LT3773558T (lt) | 2019-05-10 | 2022-09-12 | Synact Pharma Aps | Kompleksinis artrito gydymas |
| CN120617247A (zh) * | 2020-03-31 | 2025-09-12 | 西奈克制药有限公司 | 症状性病毒性疾病的治疗 |
| EP4359076B1 (en) * | 2021-06-21 | 2025-08-06 | SynAct Pharma ApS | Phenyl pyrrole aminoguanidine salts and formulations |
-
2022
- 2022-06-21 EP EP22737436.0A patent/EP4359076B1/en active Active
- 2022-06-21 IL IL309102A patent/IL309102A/en unknown
- 2022-06-21 ES ES22737436T patent/ES3045575T3/es active Active
- 2022-06-21 KR KR1020237043107A patent/KR20240024818A/ko active Pending
- 2022-06-21 AU AU2022296767A patent/AU2022296767A1/en active Pending
- 2022-06-21 JP JP2023578832A patent/JP2024523459A/ja active Pending
- 2022-06-21 CA CA3220753A patent/CA3220753A1/en active Pending
- 2022-06-21 MX MX2023014174A patent/MX2023014174A/es unknown
- 2022-06-21 JP JP2023578136A patent/JP2024522817A/ja active Pending
- 2022-06-21 EP EP22735858.7A patent/EP4359383A1/en active Pending
- 2022-06-21 EP EP25194012.8A patent/EP4684835A3/en active Pending
- 2022-06-21 WO PCT/EP2022/066884 patent/WO2022268814A1/en not_active Ceased
- 2022-06-21 KR KR1020247000873A patent/KR20240024177A/ko active Pending
- 2022-06-21 IL IL309104A patent/IL309104A/en unknown
- 2022-06-21 MX MX2023014177A patent/MX2023014177A/es unknown
- 2022-06-21 WO PCT/EP2022/066906 patent/WO2022268825A1/en not_active Ceased
- 2022-06-21 AU AU2022300305A patent/AU2022300305A1/en active Pending
- 2022-06-21 BR BR112023026909A patent/BR112023026909A2/pt unknown
- 2022-06-21 CA CA3220756A patent/CA3220756A1/en active Pending
- 2022-08-23 US US17/821,500 patent/US20230271922A9/en active Pending
- 2022-12-14 US US18/065,702 patent/US20230114865A1/en active Pending
-
2024
- 2024-05-29 US US18/676,679 patent/US12239631B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522817A5 (https=) | ||
| JPWO2023027198A5 (https=) | ||
| JP2025142338A5 (https=) | ||
| US4248858A (en) | Sustained release pharmaceutical compositions | |
| JP2022546471A5 (https=) | ||
| US20080027032A1 (en) | Combinations comprising cox-2 inhibitors and aspirin | |
| JP2005525369A5 (https=) | ||
| TW200304832A (en) | Palatable oral suspension and method | |
| EP4359076B1 (en) | Phenyl pyrrole aminoguanidine salts and formulations | |
| JP2022533368A5 (https=) | ||
| JP2020510660A5 (https=) | ||
| JP2024502446A5 (https=) | ||
| JP2023529011A (ja) | インデン化合物、その医薬組成物、及びそれらの治療応用 | |
| JP2003521511A (ja) | 便秘のためのｃｏｘ−２阻害剤の使用 | |
| US20050203115A1 (en) | Narcotic-NSAID ion pairs | |
| JP2025509278A5 (https=) | ||
| JP4608093B2 (ja) | 組合せ製剤としてのエンドセリン拮抗剤およびβ−受容体ブロッカー | |
| CN1711247A (zh) | 塞来考昔的前药 | |
| CN107018650B (zh) | 包含氨氯地平和氯沙坦的固体药物组合物 | |
| JP2665357B2 (ja) | 心不全治療用医薬組成物 | |
| JP2011246497A (ja) | イオン交換樹脂を使用する経口キノロン液状製剤の味覚マスキング | |
| JP2024540673A5 (https=) | ||
| EP4633620A1 (en) | Stat3 inhibitors for use in the treatment of non-viral liver cancer | |
| JPS5970611A (ja) | 医薬組成物 | |
| BR122025026872A2 (pt) | Forma de dosagem sólida oral de liberação imediata e seu uso |